Skip to main content
. Author manuscript; available in PMC: 2018 May 14.
Published in final edited form as: Mol Genet Metab. 2017 Apr 26;122(1-2):126–134. doi: 10.1016/j.ymgme.2017.04.010

Figure 2. Plasma Concentration-Time Profiles of ManNAc and Neu5Ac after Oral Administration of a Single Dose of 3, 6 or 10 g of ManNAc to Fasted GNE Myopathy Subjects.

Figure 2

Mean cohort and individual subject plasma concentrations (ng/mL) of ManNAc (A) and Neu5Ac (B).